Tag: FDA Commissioner

FDA Commissioner

Washington Focus

Pressure Mounting for FDA Commissioner Among Reports that Califf Will Be Biden’s Choice

Pressure Mounting for FDA Commissioner Among Reports that Califf Will Be Biden’s Choice

Oct. 21, 2021—Nine months into President Joe Biden’s administration, he has still not nominated a candidate to take the helm at the Food and Drug Administration (FDA). Amid the COVID-19 pandemic and other pressing healthcare issues, the pressure is rising for a permanent FDA commissioner, but many of the frequently-named frontrunners for the position appear […]

Read more

Regulatory/FDA

FDA at Turning Point: Kate Rawson Explains

FDA at Turning Point: Kate Rawson Explains

June 11, 2021 – The Food and Drug Administration (FDA) “is really central, not only to product approvals, but to what [medical product companies] can say in terms of marketing,” according to Prevision Policy Senior Editor Kate Rawson. Rawson, who spoke June 4 at a Coalition for Healthcare Communication (CHC) webinar, “What’s Ahead for the […]

Read more

6/4/21 Webinar: FDA Update: New leadership, initiatives and challenges

We're sorry, but all tickets sales have ended because the event is expired.

Friday, June 4, 2021, 12-1 pm ET What happens at the FDA is central to all health marketing and communications, controlling the flow of new drug approvals and regulating what manufacturers may say about their products. The agency has been through unprecedented challenges over the past two years. Now, with a new president and new (more…)

Read more

Regulatory/FDA

Woodcock to Take Helm While Biden Considers FDA Commissioner Choice

Woodcock to Take Helm While Biden Considers FDA Commissioner Choice

Jan. 18, 2021 – Under the Biden administration, longtime Center for Drug Evaluation and Research (CDER) director and FDA veteran Janet Woodcock, M.D., has been tapped to serve as the acting commissioner of the Food and Drug Administration (FDA) after current FDA Commissioner Stephen Hahn, M.D., stepped down on Jan. 20. Media reports suggest that […]

Read more

Regulatory/FDA

Myers: What the FDA Might Look Like Under Biden

Myers: What the FDA Might Look Like Under Biden

Dec. 21, 2020 – As President-elect Joe Biden takes office in January 2021, understanding what could change and what could remain the same at the FDA is important, according to Nancy Bradish Myers, president and CEO of Catalyst Healthcare Consulting Inc. Myers, who has held key positions at the FDA and in industry, spoke at […]

Read more

Washington Focus

Rawson Previews Biden COVID-19 Approach and Vaccine Roll-out

Rawson Previews Biden COVID-19 Approach and Vaccine Roll-out

Nov. 30, 2020 – Job one for President-elect Joe Biden is the response to the COVID-19 pandemic, which will represent a “marked difference in energy and tone” than that offered by the current administration and likely will include a new FDA Commissioner as well as the roll-out of COVID-19 vaccines, according to Kate Rawson, senior […]

Read more

Regulatory/FDA

Hahn: Lessons Learned in Pandemic May Lead to Permanent FDA Changes

Hahn: Lessons Learned in Pandemic May Lead to Permanent FDA Changes

June 9, 2020 – Speaking at a June 1 presentation to the Alliance for a Stronger FDA, FDA Commissioner Dr. Stephen Hahn said that despite criticisms of its performance during the COVID-19 pandemic, FDA’s “decisions [will] always be rooted in science,” and that lessons learned during the pandemic “will lead to permanent improvements at the […]

Read more

Washington Focus

Senate Confirms Hahn to Be Next FDA Commissioner

Senate Confirms Hahn to Be Next FDA Commissioner

Dec. 13, 2019 – In a vote of 72-18 the Senate yesterday confirmed Dr. Stephen Hahn to take the helm of the Food and Drug Administration even though it had been predicted that the vote to confirm Hahn as FDA Commissioner might be pushed to 2020 in light of competing priorities like the budget and […]

Read more

Washington Focus

Hahn Confirmation Hearing Reveals Little about FDA Commissioner Nominee

Hahn Confirmation Hearing Reveals Little about FDA Commissioner Nominee

Nov. 20, 2019 – In today’s Senate confirmation hearing for Dr. Stephen Hahn, President Donald Trump’s nominee for the Commissioner of Food and Drugs position, Senate Health, Education, Labor, and Pensions (HELP) Committee members questioned Hahn on such topics as opioids, generic drugs, updating the over-the-counter drug monograph, regulating cannabis-related products, and combatting shortages of […]

Read more

Regulatory/FDA

Dr. Stephen Hahn Nominated for FDA Commissioner Position

Dr. Stephen Hahn Nominated for FDA Commissioner Position

Nov. 1, 2019 – In a statement issued by the White House, President Donald J. Trump today nominated Stephen Hahn, M.D., to be Commissioner of the Food and Drug Administration (FDA). Hahn is a radiation oncologist, experienced clinical trial investigator, and coauthor of more than 200 papers. He previously served as Chair of Radiation Oncology […]

Read more